发明名称 |
REMEDIES FOR LIVER DISEASES, HYPERLIPEMIA AND DIABETES |
摘要 |
Agents for treating and preventing hepatopathies, hyperlipemia and/or diabetes comprise a peptide composed of L-amino acids constituting natural proteins, having a L-glutamine content of 15-60 weight% and having an average molecular weight of 200-100000. ACTIVITY : Hepatotropic; Antilipemic; Antidiabetic; Antiinflammatory; Virucide. In a volunteer with fatty liver administration of a glutamine peptide (GP-1; average molecular weight = 7000; L-glutamine content is 32 weight%) at 9.9 g/day after 3 weeks gave glutamic oxaloacetic transaminase levels of 16 IU/l and glutamic pyruvic transaminase levels of 25 IU/l compared to 72 and 124 IU/l respectively at the beginning of the test. MECHANISM OF ACTION : Cholesterol-Antagonist. |
申请公布号 |
EP1481684(A4) |
申请公布日期 |
2008.04.02 |
申请号 |
EP20030743531 |
申请日期 |
2003.02.28 |
申请人 |
NISSHIN PHARMA INC. |
发明人 |
HORIGUCHI, NOBORU;HORIGUCHI, HIROSHI;SUZUKI, YOSHIO |
分类号 |
A21D2/24;A21D2/26;A23J3/34;A23L1/09;A23L1/16;A23L1/305;A23L1/39;A61K38/01;A61K38/16;A61P1/16;A61P3/06;A61P3/10 |
主分类号 |
A21D2/24 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|